{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:44:15Z","timestamp":1782776655352,"version":"3.54.5"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Reconstr Microsurg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A significant proportion of patients experience symptoms of sensory nerve damage from chemotherapy known as chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a major dose-limiting toxicity of many chemotherapeutic regimens. Early detection and quantification of CIPN is a significant challenge. It is hypothesized that noninvasive, nonpainful, pressure-specified sensory device (PSSD) will be a sensitive and specific tool for measuring CIPN. If CIPN can be detected early, then oncology might alter the drug regimen. Additionally, it is known that more than 33% of diabetics with neuropathy have a chronic nerve entrapment, as determined by a positive Tinel sign. If CIPN persisted after chemotherapy stopped, then presence of a peripheral nerve entrapment could be evaluated.<\/jats:p>\n                  <jats:p>A prospective cohort of patients receiving chemotherapy were referred by their oncologist. During the administration of their intravenous (IV) chemotherapy, the patient had PSSD testing of the index, little finger, and finger and big toe pulp. Quality-of-life outcome instruments QLQ-CIPN20, and the Michigan Neuropathy Symptom Score Instrument were administered. Each patient was evaluated for the presence of a Tinel sign at known sites of nerve entrapment. Inclusion criteria were patients receiving neurotoxic chemotherapy (Vincristine, Taxol, or Cisplatin).<\/jats:p>\n                  <jats:p>Thirteen patients were enrolled. There were no complications from neurosensory testing. The PSSD was 80% sensitive and 100% specific identifying symptomatic neuropathy, p\u2009&lt;\u20090.014, chi square and p\u2009&lt;\u20090.05 using the Fisher's exact test. PSSD testing became abnormal prior to the patient becoming symptomatic and prior to the presence of a positive Tinel sign.<\/jats:p>\n                  <jats:p>Noninvasive and nonpainful neurosensory testing is feasible to do during chemotherapy IV infusion. This can identify changes in peripheral nerve function that correlate with a patient's symptoms and therefore might be used by the oncologist to alter the patient's chemotherapy dosage and limiting chemotherapy toxicity.<\/jats:p>","DOI":"10.1055\/a-2856-1305","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:17:32Z","timestamp":1781219852000},"source":"Crossref","is-referenced-by-count":0,"title":["Sequential, Noninvasive, Neurosensory Monitoring During Chemotherapy: Clinical Consequences of Identifying Neuropathy"],"prefix":"10.1055","author":[{"given":"Norah","family":"Oles","sequence":"additional","affiliation":[{"name":"The Johns Hopkins University School of Medicine, United States","department":["Department of Plastic Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Iverson","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Hygiene and Public Health, United States","department":["Department of Plastic Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanial H.","family":"Williams","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine School of Medicine, United States","department":["Department of Plastic Surgery"]},{"name":"Dellon Institute for Peripheral Nerve Surgery, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Wagner-Johnson","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine School of Medicine, United States","department":["Departments of Neurosurgery and Plastic Surgery"]},{"name":"Sidney Kimmel Cancer Center, Johns Hopkins University, United States","department":["Department of Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Grossman","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine School of Medicine, United States","department":["Departments of Neurosurgery and Plastic Surgery"]},{"name":"Sidney Kimmel Cancer Center, Johns Hopkins University, United States","department":["Department of Oncology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Lee","family":"Dellon","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine School of Medicine, United States","department":["Departments of Neurosurgery and Plastic Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"08","key":"ref1","first-page":"2281","article-title":"Management options for established chemotherapy-induced peripheral neuropathy","volume":"22","author":"D R Pachman","year":"2014","journal-title":"Support Care Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/bs.pmbts.2014.12.002","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"131","author":"J C Fehrenbacher","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-16366-6_6","article-title":"Symptoms: chemotherapy-induced peripheral neuropathy","volume":"862","author":"B P Schneider","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"R Zaj\u0105czkowska","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.seminoncol.2021.09.004","article-title":"Chemotherapy-induced peripheral neuropathy and rehabilitation: s review","volume":"48","author":"S Zhang","year":"2021","journal-title":"Semin Oncol"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s13311-021-01142-2","article-title":"Chemotherapy-induced peripheral neuropathy: mechanisms and therapeutic avenues","volume":"18","author":"E H Bae","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2006-947153","article-title":"Utility of decompressive surgery in the prophylaxis and treatment of cisplatin neuropathy in adult rats","volume":"16","author":"P Tassler","year":"2000","journal-title":"J Reconstr Microsurg"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.PRS.0000132671.89418.73","article-title":"Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves","volume":"114","author":"A L Dellon","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/01.prs.0000218800.92324.fc","article-title":"Thalidomide-induced neuropathy: treatment by decompression of peripheral nerves","volume":"117","author":"M I Rose","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/1097-0274(200103)39:3<254::AID-AJIM1013>3.0.CO;2-P","article-title":"Associations of tibia lead, DMSA-chelatable lead, and blood lead with measures of peripheral nervous system function in former organolead manufacturing workers","volume":"39","author":"P L Tassler","year":"2001","journal-title":"Am J Ind Med"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1012554328801","article-title":"Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme","volume":"54","author":"G M Marx","year":"2001","journal-title":"J Neurooncol"},{"key":"ref12","first-page":"334","article-title":"Early diagnosis of diabetic entrapment neuropathy management with quantitative sensory-motor testing","volume":"20","author":"M Siemionow","year":"2004","journal-title":"J Reconstr Microsurg"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.sap.0000185888.44243.d5","article-title":"Detection of neuropathy due to Mycobacterium leprae using noninvasive neurosensory testing of susceptible peripheral nerves","volume":"55","author":"D K Seiler","year":"2005","journal-title":"Ann Plast Surg"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.sap.0000210634.98344.47","article-title":"Comparison of clinical evaluation and neurosensory testing in the early diagnosis of superimposed entrapment neuropathy in diabetic patients","volume":"57","author":"M Siemionow","year":"2006","journal-title":"Ann Plast Surg"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2106\/00004623-200308000-00011","article-title":"Nerve lesions associated with limb-lengthening","volume":"85","author":"M P Nogueira","year":"2003","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11136-013-0379-8","article-title":"Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire","volume":"22","author":"E M Lavoie Smith","year":"2013","journal-title":"Qual Life Res"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","article-title":"Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy","volume":"108","author":"A Moghtaderi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/01.sap.0000141379.55618.87","article-title":"Prognostic ability of Tinel sign in determining outcome for decompression surgery in diabetic and nondiabetic neuropathy","volume":"53","author":"C H Lee","year":"2004","journal-title":"Ann Plast Surg"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0032-1306371","article-title":"A positive Tinel sign as predictor of pain relief or sensory recovery after decompression of chronic tibial nerve compression in patients with diabetic neuropathy","volume":"28","author":"A L Dellon","year":"2012","journal-title":"J Reconstr Microsurg"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<285::AID-MUS2>3.0.CO;2-9","article-title":"Pressure perception in the normal lower extremity and in the tarsal tunnel syndrome","volume":"19","author":"P L Tassler","year":"1996","journal-title":"Muscle Nerve"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000637-199705000-00009","article-title":"Computer-assisted quantitative sensorimotor testing in patients with carpal and cubital tunnel syndromes","volume":"38","author":"A L Dellon","year":"1997","journal-title":"Ann Plast Surg"},{"issue":"12","key":"ref22","first-page":"4753","article-title":"Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy","volume":"27","author":"F Yeo","year":"2019","journal-title":"Support Care Cancer"},{"key":"ref23","first-page":"3","article-title":"Prevalence of the Tinel sign in extremities of patients with diabetes in a community-based practice","volume":"4","author":"S S Hashemi","year":"2013","journal-title":"J Diabetes Metab"},{"key":"ref24","volume-title":"Somatosensory Testing and Rehabilitation","author":"A L Dellon","year":"1997"}],"container-title":["Journal of Reconstructive Microsurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2856-1305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:50:15Z","timestamp":1782773415000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2856-1305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1055\/a-2856-1305","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0743-684X","1098-8947"],"issn-type":[{"value":"0743-684X","type":"print"},{"value":"1098-8947","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,11]]},"published":{"date-parts":[[2026,6,11]]}}}